Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,018 across all filing types
Latest filing 2021-02-25 Annual Report
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
2020 integrated annual report - NL.pdf
Annual Report Classification · 1% confidence The document is titled 'GEÏNTEGREERD JAARVERSLAG 2020' (Integrated Annual Report 2020) for the company UCB. It contains comprehensive financial data, management reports, governance statements, and audit information for the full fiscal year 2020. It is clearly the primary annual reporting document, not an announcement or a summary. FY 2020
2021-02-25 Dutch
20210222 - Disposals of own shares.pdf
Transaction in Own Shares Classification · 1% confidence The document is explicitly titled 'Disposals of own shares' and details transactions where the company disposed of UCB shares OTC following the exercise of stock options under its Long Term Incentive Program. This directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase/issuance). The filing is short and contains specific transaction data, making POS the most accurate classification over a general regulatory filing (RNS).
2021-02-22 English
20210222 - Aliénation d'actions propres.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Aliénation d'actions propres" (Alienation of own shares) and details transactions where UCB SA sold shares back to the market (OTC) to cover obligations arising from the exercise of stock options by employees as part of long-term variable remuneration. This directly corresponds to the definition of a company reporting transactions involving its own shares, specifically share repurchase or issuance, which maps to the 'Transaction in Own Shares' category (POS). The document is a formal announcement dated February 22, 2021, referencing Belgian Royal Decree requirements, confirming it is a specific regulatory disclosure about share transactions.
2021-02-22 French
20210222 - Vervreemding van eigen aandelen.pdf
Transaction in Own Shares Classification · 1% confidence The document title is "Vervreemding van eigen aandelen" (Disposal of own shares) and the content details the number of UCB shares disposed of (sold/delivered) following the exercise of options by employees under Long-Term Incentive (LTI) plans. This directly relates to the company buying back or issuing its own shares, specifically in the context of employee stock options being settled via share delivery. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS). The document is a formal announcement of this transaction, not a general regulatory filing (RNS) or a report publication announcement (RPA), as it contains the specific transaction details.
2021-02-22 Dutch
210212 - Disposals of own shares.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Disposals of own shares" and details transactions where UCB SA/NV disposed of its own shares OTC following the exercise of stock options by personnel under various incentive plans (Stock Option Plan 2011, Stock Award Plan 2018). This activity directly relates to the company buying back or issuing its own shares, specifically in the context of employee compensation/incentives. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS), which covers share repurchase or issuance activities. The document is a direct announcement of these transactions, not an announcement of a report.
2021-02-12 English
210212 - Aliénation d'actions propres.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Aliénation d'actions propres" (Alienation of own shares) and details transactions where UCB SA disposed of its own shares following option exercises by personnel, as required by Belgian Royal Decree Article 8:6. This specifically concerns the company buying back or selling its own shares, often related to employee compensation plans. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS). The document is a formal announcement of these transactions, not a general regulatory filing (RNS) or a report publication announcement (RPA), as it contains the core transactional data.
2021-02-12 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.